Get 50% OFF This Summer!

Advertisement
logo

Shelter Pharma

543963
Micro Cap
(%) 1D
no_data

No Data Available

1D1W1M3M6M1YMAX

Investor Sentiment

50%50%
Bullish
Bearish
Advertisement

Shelter Pharma Share price and Fundamental Analysis

View All Details
View All Details
Shelter Pharma Ltd originally named as Shelter Pharmacy, was converted from a Partnership Firm 'M/s Shelter Pharma' to a Public Limited Company under the name 'Shelter Pharma Limited' on 12 October, 2007 with the Registrar of Companies, Gujarat. The Company is being promoted by Mr. Mustaqim Nisarahmed Sabugar and Mr. Shakil Nisarahmed Sabugar.
Company Incorporation2007
ChairmanNA
Head QuartersNA
Previous NameNA

Key Metrics

Market Cap (Cr)
41.85
PE Ratio
6.65
Industry P/E
31.29
PEG Ratio
1.04
ROE
16.92%
ROCE
22.17%
ROA
15.5%
Total Debt (Cr)
1.11
Debt to Equity
0.03
Dividend Yield
0%
EPS
5.44
Book Value & P/B
30.17 x 1.2
Face Value
10
Outstanding Shares(Cr)
1.16
Current Ratio
13.44
EV to Sales
0.88

Stock Returns

1 Week-5.19%
1 Month-9.43%
6 Months-33.62%
1 Year-35.96%
3 Years-13.01%
5 Years-13.01%

CAGR

1 Year CAGR

Revenue Growth

+10.71%

Net Profit Growth

+7.21%

Operating Profit Growth

+6.39%

Dividend Growth

N/A

Stock Returns CAGR

-35.96%
no_data

No Stocks

Smart Score

2
icn

Unlock Smart Score

See Detailed Analysis & Insights

icn

Unlock Insights

See Detailed Analysis & Insights

Technicals

Returns Calculator

If you would have invested
In 5 years the current value would be
NaNCRNaNCR( %)

Research Report

No Research Report

View Other Reports >

Corporate Action

Board-Meetings
Board-Meetings
Dividends
Bonus
Splits
Right-issues
AGM-EGM
Bulk-Deal
Block-Deal

Financials

Profit and Loss Statement

Credit Rating
Director Report
Chairman Report
Auditor Report
Mar 25

Promoters : 52.32%

FIIs : 0.00%

DIIs : 0.00%

Public : 47.68%

Promoter
FII/FPI
DII
Public
Promoter Pledge stands at 0.0% of holding in March 2025 Qtr
Promoter Shareholding Decreased by 2.65% to 52.32% in March 2025 Qtr

Top Shareholders

View all Share Holders

Key Ratios

Profitability
Valuation
Liquidity

ROE

Avg ROE (3 Yrs) : NaN%

ROCE

Avg ROCE (3 Yrs) : NaN%

ROA

Avg ROA (3 Yrs) : NaN%

NPM

Avg NPM (3 Yrs) : NaN%

Dividend History

Shelter Pharma Competitors

Sector
Industry

Company Name

MCap(TTM)

PE(TTM)

P/B(TTM)

ROE(TTM)

D/E

Current Ratio(TTM)

5 Year FactSheet

Profitability
Profitability
Growth Ratios
Valuation Ratios
Cashflow Ratios
Debt and Liquidity
Efficiency Ratios

Documents

Annual Reports
Con-Call

News

Shelter Pharma Management and History

Company Management

icn

Unlock Management Data

See Detailed Analysis & Insights

Company History

Shelter Pharma Ltd originally named as Shelter Pharmacy, was converted from a Partnership Firm 'M/s Shelter Pharma' to a Public Limited Company under the name 'Shelter Pharma Limited' on 12 October, 2007 with the Registrar of Companies, Gujarat. The Company is being promoted by Mr. Mustaqim Nisarahmed Sabugar and Mr. Shakil Nisarahmed Sabugar.

The Company primarily focuses in manufacturing of ayurvedic and herbal products with well-built presence in Human Pharma as well as Veterinary space. The Company started with a few products about decades back. However, over a period of time, it has added products to portfolio through in-house R & D efforts backed by sound knowledge of Ayurveda.

The business was slowly expanded from local presence in Himmatnagar to well spread presence in the State of Gujarat. The Company remained a family enterprise before incorporation of the Company with a consolidated position in Gujarat. Introduction of new generation of promoters, set up of new companies around 2007 brought new ideas and aspirations to the business.

The Company has reworked its organizational structure, product portfolio, distribution network, pricing, packaging and internal processes. It also invested substantially in strengthening infrastructure with fresh fund infusion to improve its manufacturing capacity in Himmatnagar. Apart from these, it sources required raw material from nearby villages, directly from farmers. It has long relationships with farmers, giving an assured supply of herbs and plants. It focuses on rural/semi urban market as its clientele to offer high quality price competitive remedies to villages.

As of now, the Company is present in most of non-critical segment of Human as well as Veterinary Pharma through its well spread portfolio. It enjoys a good product acceptance and market share in the State of Gujarat. In the Human pharma segment, the Company has product portfolio of OTC products as well Ethical pharma products. Similarly, it has OTC and Ethical presence in Veterinary segment. It has a respectable track record of efficacy of its products. Presently, it is moving aggressively to tap these opportunities with geographical expansion backed by intense marketing & branding efforts.

The Company is planning to issue 38,50,000 Equity Shares by raising of capital amounting to Rs 20.02 crore through Fresh Issue.

Shelter Pharma Share Price

Shelter Pharma share price reflects investor sentiment toward the company and is impacted by various factors such as financial performance, market trends, and economic conditions. Share price is an indicator which shows the current value of the company's shares at which buyers or sellers can transact.

Shelter Pharma Market Cap

Market capitalization of Shelter Pharma indicates the total value of its outstanding shares. Marketcap is calculated by multiplying share price and outstanding shares of the company. It is a helpful metric for assessing the company's size and market Valuation. It also helps investors understand how Shelter Pharma is valued compared to its competitors.

Shelter Pharma PE Ratio

Shelter Pharma PE ratio helps investors understand what is the market value of each stock compared to Shelter Pharma 's earnings. A PE ratio higher than the average industry PE could indicate an overvaluation of the stock, whereas a lower PE compared to the average industry PE could indicate an undervaluation.

Shelter Pharma PEG Ratio

The PEG ratio of Shelter Pharma evaluates its PE ratio in relation to its growth rate. A PEG ratio of 1 indicates a fair value, a PEG ratio of less than 1 indicates undervaluation, and a PEG ratio of more than 1 indicates overvaluation.

Shelter Pharma ROE (Return on Equity)

Return on Equity (ROE) measures how effectively Shelter Pharma generates profit from shareholders' equity. A higher ROE of more than 20% indicates better financial performance in terms of profitability.

Shelter Pharma ROCE (Return on Capital Employed)

Return on Capital Employed (ROCE) evaluates the profitability of Shelter Pharma in relation to its capital employed. In simple terms, ROCE provides insight to investors as to how well the company is utilizing the capital deployed. A high ROCE of more than 20% shows that the business is making profitable use of its capital.

Shelter Pharma Total Debt

Total debt of Shelter Pharma shows how much the company owes to either banks or individual creditors. In simple terms, this is the amount the company has to repay. Total debt can be a very useful metric to show the financial health of the company. Total debt more than equity is considered to be a bad sign.

Shelter Pharma Debt to Equity Ratio

The Debt-to-Equity (DE) ratio of Shelter Pharma compares its total debt to shareholders' equity. A higher Debt to Equity ratio could indicate higher financial risk, while a lower ratio suggests that the company is managing its debt efficiently.

Shelter Pharma CAGR (Compound Annual Growth Rate)

CAGR shows the consistent growth rate of Shelter Pharma over a specific period, whether it is over a month, a year, or 10 years. It is a key metric to evaluate the company’s long-term growth potential. Main metrics for which CAGR is calculated are net sales, net profit, operating profit, and stock returns.

Shelter Pharma Technical Analysis

Technical analysis of Shelter Pharma helps investors get an insight into when they can enter or exit the stock. Key components of Shelter Pharma Technical Analysis include:

Support Levels (S1, S2, S3)

There are usually multiple support levels, but the main support levels for a stock are S1, S2, S3. Support levels indicate price points where stock might get support from buyers, helping the stock stop falling and rise.

Resistance Levels (R1, R2, R3)

There are usually multiple resistance levels, but the main resistance levels for a stock are R1, R2, R3. Resistance levels represent price points where Shelter Pharma shares often struggle to rise above due to selling pressure.

Shelter Pharma Dividends

Dividends refer to the portion of the company’s profits distributed to its shareholders. Dividends are typically paid out in cash and reflect Shelter Pharma ’s financial health and profitability.

Shelter Pharma Bonus Shares

Bonus shares are usually given by companies to make the stock more affordable, increase liquidity, boost investor confidence, and more.

Shelter Pharma Stock Split

Stock split increases the number of its outstanding shares by dividing each existing share into multiple shares. When the company offers a stock split, the face value of the stock reduces in the same proportion as the split ratio.

Shelter Pharma Financials

The financials of Shelter Pharma provide a complete view to investors about its net sales, net profit, operating profits, expenses, and overall financial health. Investors can analyze financial data to assess the company’s stability and also understand how the company has been growing financially.

Shelter Pharma Profit and Loss Statements

The profit and loss statement of Shelter Pharma highlights its net sales, net profit, total expenditure, and operating profits in the current financial year. This Profit and Loss statement is crucial for evaluating the profitability and financial stability of Shelter Pharma .

Shelter Pharma Balance Sheet

The balance sheet presents a snapshot of Shelter Pharma ’s assets, liabilities, and equity of shareholders, providing insights into the financials of the company.

Shelter Pharma Cashflow Statements

Cashflow statements track the company's cash inflows and outflows over a period. It is an essential tool for understanding how well the company manages its liquidity and finances.

Download the App